InCephalo raises €1.4M Pre-Seed round
1 September 2021· Allschwil, Switzerland· health, oncology, biotech, b2b, deep_hardware
The funding will be used to advance its lead candidate, a compartment-locked cytokine for the local treatment of brain cancer (glioblastoma), through preclinical development.
Investors
Leadredalpine
Also participating
Schroder AdveqUZH Lifesciences Fund
About InCephalo
Stage
Seed
Headquarters
Allschwil, Switzerland
Founded
2021
Team Size
6–20
Sectors
healthoncologybiotechb2bdeep_hardware